• BioCode MDx 3000 High Throughput System
  • BioCode 2500 Analyzer
  • Barcoded Magnetic Beads
  • Gastrointestinal Pathogen Panel
  • Applied BioCode Capabilities

Digital Multiplexing for Proteomics and Genomics


Applied BioCode provides a breakthrough digital multiplexing molecular platform that delivers easy to use, low cost, multiplex analysis for all of your Molecular and Protein testing needs. At the core of the platform are the micrometer scaled Barcode Magnetic Beads or BMBs that are 1,000 times smaller than conventional barcodes and can be used to barcode all of your biomarkers for all-in-one molecular tests. These BMBs are biocompatible polymeric magnetic beads that are encoded with a digital barcode for easy and accurate recognition. Our high contrast optical barcodes enable accurate decoding without risk of ambiguous test classifications.

Multiplex Applications:

- Molecular Testing
- Protein Biomarkers
- Single Nucleotide Polymorphism(SNPs)
- Gene Expression
- Micro RNA Expression
- Human Leukocyte Antigen
- Blood Group Genotyping
- In vitro fertilization biomarkers
- Agriculture product and seed genotyping
- Biomarker Discovery

DNA & Protein Multiplex Assays


  • Technology

    • Watch Video about Barcoded Magnetic Bead (BMB) Technology

    • Watch Video about The BioCode MDx 3000*

    • Watch Video about User-Defined Mode on the BioCode MDx 3000*

    Applied BioCode, Inc. has combined photolithographic digital barcodes with immuno- and molecular chemistry to create a new, patented Barcoded Magnetic Beads (BMB) technology. The BMBs' barcode patterns (4,096 available barcodes) produce a high-contrast signal with a nominal fluorescent background, allowing the barcode to be easily and accurately identified, with near 100% decoding accuracy.




    Experience Next Generation Multiplexing Technology with Digitally Barcoded Magnetic Beads!

    Benefits include:
    • Pre-Mixed or Custom Panels
    • Partial Plates Available – 32 or 96 Test Kits
    • Just like ELISA, with Direct Imaging
    • No Lasers, No Flow Cells, No Fluids, No Waste
    • Up to 40% Lower Prices than Competitive Offerings


    News and Events

    Jan 8th, 2018 - IDEXX to Introduce Applied BioCode's Innovative Multiplex Technology Across Global Reference Laboratory Network

    Jan 3rd, 2018 - Applied BioCode Submits 510(k) Application to FDA) for BioCode MDx-3000 with Gastrointestinal Pathogen Panel

    May 30th, 2017 - Applied BioCode has received ISO 13485:2003 certification (FM 661595) from the British Standards Institution (BSI) Group for the design, development, manufacture and distribution of in-vitro diagnostic reagents and in-vitro medical devices used in molecular and protein detection.

    March 29th, 2017 - Press Release: Applied BioCode Completes Beta Sites for Molecular Diagnostic System.

    February 9th, 2017 - Press Release: Applied BioCode Listed on Taiwan Emerging Market Stock Exchange (6598).

    June 16th, 2016 - Press Release: Applied BioCode Inks Partnership and Supply Agreement with Diatherix for Multiplex MDx Reference Laboratory Testing.



    About Us

    Our mission is to develop and commercialize high quality BioCode systems, easy-to-use, reliable multiplexed testing instruments and customized assays for the global In-Vitro Molecular Diagnostic markets. In doing this, we will reduce test turn around time, reduce the labor required to test patients, decrease patient sample size requirements, and improve the cost structure of laboratory testing. This will in turn help to reduce healthcare costs and improve patient outcomes.


*The BioCode MDx 3000 and the associated GI Panel are currently in clinical studies and have not been cleared for marketing by the FDA.